HYTN Innovations Inc (TSE:HYTN) has released an update.
HYTN Innovations Inc. has welcomed a Health Canada audit, aiming to bolster its Good Manufacturing Practices (GMP) capabilities following a recent GMP certification from Australia’s TGA. This audit is crucial for HYTN as it seeks to expand its production and sale of cannabis and psilocybin products, with an eye on global markets and regulatory requirements for drug development. The company underlines its commitment to quality and transparency, promising updates on the audit’s progress.
For further insights into TSE:HYTN stock, check out TipRanks’ Stock Analysis page.